Stay updated on Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page
- Check5 days agoChange DetectedA site-wide NIH notice announces the transition from “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434. The site revision label also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe site footer revision marker changes from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden message.SummaryDifference0.2%

- Check32 days agoChange DetectedThe study page now displays a 403 Forbidden error screen with a minimal header and a Home button, replacing the previous study details and navigation. This indicates an access-denied state rather than an update to the study information.SummaryDifference19%

- Check39 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This reflects a system update rather than changes to the study content.SummaryDifference0.1%

- Check53 days agoChange DetectedThe site’s revision tag was updated from v3.6.5 to v3.6.6, indicating a small update to the platform rather than a change to study information.SummaryDifference0.1%

- Check74 days agoChange DetectedPlatform upgrade from v3.6.4 to v3.6.5. This appears to be an internal update to the site’s platform and rendering, with no visible changes to the study content on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.